Measurable residual disease in hematologic malignancies: a biomarker in search of a standard

Summary: Over the past decade, measurable residual disease (MRD) has emerged as a critical tool for detecting and monitoring a variety of cancers, but particularly hematologic malignancies. The rapid adaptation of this novel approach to monitoring disease status is intuitively appealing: it offers s...

Full description

Saved in:
Bibliographic Details
Main Authors: Namrata S. Chandhok, Mikkael A. Sekeres
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537025002809
Tags: Add Tag
No Tags, Be the first to tag this record!